<?xml version="1.0" encoding="UTF-8"?>	<item><status>past</status><description>&lt;p&gt;&lt;span style="color : #000000"&gt;&lt;strong&gt;Boston Biotech Business Development Conference 2012&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;When: April 17-18, 2012&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Where: Mandarin Oriental Hotel, 776 Boylston Street, Boston&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Register: &lt;a target="_blank" style="color : #0000FF ; text-decoration : underline"&gt;http://bbbiotechconference.com/conference-agenda.php?id=10&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;(Please call reservations at the Mandarin Oriental Hotel today to book your accommodations at the special rate for the Boston Biotech Conference.&lt;/span&gt; Room Reservations: Telephone: +1 (617) 535 8880 or +1 (866) 526 6567)&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;The Boston Biotech Business Development Conference is a networking forum for industry professionals offering exclusive access to the key decision makers who influence deal making and investment in the life sciences. Attendees will gain insights from presentations and panels featuring business development decision-makers from several of the world's leading pharmaceutical and biotechnology companies, on the current and future outlook for licensing, M&amp;amp;A and other business development activities in the life sciences sector. In between learning what it takes to get a deal done in biotech, the Business Development Conference offers opportunities throughout the day to network one-on-one with the industry's top deal makers - senior executives from biotech and pharma, leaders from Wall Street and venture capitalists.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Past participants include:&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;* Ad Rawcliffe, S.V.P., Worldwide Business Development, GlaxoSmithKline&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* Barbara Yanni, V.P. and Chief Licensing Officer, Merck&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* Robert Bagdorf, Pfizer, VP, Business Development&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* Merv Turner, SVP Worldwide Licensing and External Research&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* John Maraganore, CEO, Alnylam&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* David Pyott, CEO, Allergan&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* Adelene Perkins, CEO Infinity Pharmaceuticals&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* Bob Coughlin, President, Mass Biotech Council&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* Chris Gabrieli, Co-founder and Chairman, Massachusetts 2020 Foundation&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* Wyc Grousbeck, CEO and Owner, Boston Celtics&lt;/span&gt; &lt;br /&gt;

&lt;span&gt;* JF Formela, Partner, Atlas Ventures&lt;/span&gt;&lt;/p&gt;</description><event_hosts><event_hosts_item><member_name>Joshua Lang</member_name><member_id>3926861</member_id></event_hosts_item></event_hosts><maybe_rsvp_count>0</maybe_rsvp_count><waitlist_count>0</waitlist_count><updated>1334668466000</updated><rating><average>0.0</average><count>0</count></rating><group><who>Scientific Members</who><join_mode>open</join_mode><urlname>nexusproject</urlname><id>1294865</id><group_lat>42.3699989319</group_lat><group_lon>-71.0999984741</group_lon><name>Nexus Project</name></group><yes_rsvp_count>6</yes_rsvp_count><created>1325813845000</created><visibility>public</visibility><name>Boston Biotech Business Development Conference 2012</name><id>46881452</id><headcount>0</headcount><utc_offset>-14400000</utc_offset><time>1334664000000</time><event_url>http://www.meetup.com/nexusproject/events/46881452/</event_url></item>